Abbott's Phensedyl Supply Chain Under Scanner After Ghaziabad Seizure, Codeine Diversion Probe Widens
Written By : sheeba farhat
Published On 2026-01-24 15:35 GMT | Update On 2026-01-24 15:35 GMT
Advertisement
Ghaziabad: Indian drugmaker Abbott Healthcare's supply chain is being scrutinised as part of a wider investigation into the alleged misuse of its codeine-based cough syrup which is prone to abuse by addicts, documents show.
Abbott's Phensedyl contains codeine, which is a narcotic used in cough suppressants that are also abused by addicts, including in neighbouring Bangladesh, where it is banned but has historically been smuggled from India. Abbott Healthcare, a unit of U.S.-based Abbott Laboratories, discontinued its manufacturing of Phensedyl in December 2024, but the drug remains in its supply chain.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.